Danaher (DHR) Financials: History & Chart

Danaher Corporation (DHR)DHRDanaher Corporation

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC

61,000 employees

www.danaher.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Rainer Blair

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	25.11B	6.26B	5.95B	6.84B	6.05B	5.94B	5.74B	6.54B	5.80B
Cost of Goods Sold	10.42B	2.65B	2.36B	2.87B	2.53B	1.98B	2.23B	2.65B	2.40B
Gross Profit	14.69B	3.61B	3.59B	3.97B	3.52B	3.96B	3.51B	3.89B	3.40B
Gross Profit Margin	58.5%	57.6%	60.3%	58.0%	58.2%	66.6%	61.2%	59.5%	58.7%
Total Operating Expenses	9.56B	2.48B	2.25B	2.46B	2.37B	2.76B	2.24B	2.14B	2.44B
Research & Development	1.61B	412.00M	387.00M	438.00M	378.00M	403.00M	379.00M	442.00M	383.00M
Selling, General & Administrative	7.95B	2.07B	1.86B	2.03B	1.99B	2.36B	1.86B	1.70B	2.06B
Operating Income (EBIT)	5.13B	1.13B	1.34B	1.50B	1.15B	1.19B	1.27B	1.75B	958.00M
Operating Margin	20.4%	18.0%	22.6%	22.0%	19.1%	20.1%	22.2%	26.7%	16.5%
Income Before Tax (EBT)	4.76B	1.08B	1.24B	1.37B	1.08B	655.00M	1.13B	1.31B	977.00M
Interest Income	104.00M	61.00M	27.00M	13.00M	3.00M	8.00M	6.00M	14.00M	4.00M
Interest Expense	78.00M	-107.00M	63.00M	55.00M	67.00M	71.00M	72.00M	61.00M	87.00M
Other Income/Expense	-365.00M	-49.00M	-109.00M	-129.00M	-78.00M	-537.00M	-145.00M	-431.00M	19.00M
Net Income	4.00B	870.00M	1.03B	1.20B	908.00M	555.00M	954.00M	1.09B	818.00M
Income Tax Expense	758.00M	208.00M	206.00M	176.00M	168.00M	100.00M	175.00M	229.00M	159.00M
Net Profit Margin	15.9%	13.9%	17.3%	17.5%	15.0%	9.3%	16.6%	16.6%	14.1%
EBITDA	6.57B	1.13B	1.54B	2.13B	1.78B	1.80B	1.86B	2.34B	1.55B
EBITDA Margin	26.1%	18.0%	25.8%	31.1%	29.3%	30.4%	32.5%	35.8%	26.7%
Depreciation & Amortization	1.44B	0.00	193.00M	623.00M	622.00M	611.00M	591.00M	595.00M	591.00M
EPS Basic	5.65	1.23	1.45	1.69	1.28	0.77	1.33	1.50	1.13
EPS Diluted	5.63	1.23	1.45	1.68	1.27	0.77	1.32	1.49	1.12
Shares Outstanding	705.30M	705.30M	707.90M	707.30M	710.70M	716.50M	716.30M	731.00M	723.00M
Diluted Shares Outstanding	707.60M	707.60M	711.20M	711.00M	713.70M	719.10M	720.80M	737.20M	729.40M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	24.57B	23.88B	23.89B	26.64B	29.45B	22.28B	17.91B	17.05B
Cost of Goods Sold	9.60B	9.67B	9.86B	10.46B	11.50B	9.81B	7.93B	7.54B
Gross Profit	14.97B	14.21B	14.03B	16.19B	17.95B	12.47B	9.98B	9.51B
Gross Profit Margin	60.9%	59.5%	58.7%	60.8%	61.0%	56.0%	55.7%	55.8%
Total Operating Expenses	9.83B	9.02B	8.76B	8.65B	9.90B	8.16B	6.62B	6.44B
Research & Development	1.60B	1.58B	1.50B	1.53B	1.74B	1.35B	1.13B	1.06B
Selling, General & Administrative	8.23B	7.44B	7.25B	7.12B	8.16B	6.82B	5.50B	5.38B
Operating Income (EBIT)	5.14B	5.18B	5.28B	7.54B	8.05B	4.31B	3.36B	3.07B
Operating Margin	20.9%	21.7%	22.1%	28.3%	27.3%	19.4%	18.8%	18.0%
Income Before Tax (EBT)	4.23B	4.65B	5.04B	7.15B	7.60B	4.50B	3.31B	2.96B
Interest Income	30.00M	117.00M	303.00M	41.00M	11.00M	71.00M	139.00M	9.20M
Interest Expense	265.00M	278.00M	289.00M	207.00M	241.00M	273.00M	108.60M	136.90M
Other Income/Expense	-904.00M	-538.00M	-235.00M	-390.00M	-452.00M	183.00M	-57.10M	-108.20M
Net Income	3.61B	3.90B	4.76B	7.21B	6.43B	3.65B	2.56B	2.65B
Income Tax Expense	619.00M	747.00M	823.00M	818.00M	1.25B	849.00M	873.00M	555.60M
Net Profit Margin	14.7%	16.3%	19.9%	27.1%	21.8%	16.4%	14.3%	15.5%
EBITDA	7.58B	7.54B	7.45B	9.67B	10.22B	6.09B	4.55B	4.25B
EBITDA Margin	30.9%	31.6%	31.2%	36.3%	34.7%	27.3%	25.4%	24.9%
Depreciation & Amortization	2.45B	2.35B	2.17B	2.13B	2.17B	1.77B	1.19B	1.18B
EPS Basic	5.07	5.33	6.44	9.80	8.77	4.97	3.48	3.78
EPS Diluted	5.04	5.29	6.38	9.64	8.61	4.89	3.43	3.73
Shares Outstanding	707.30M	731.00M	736.50M	725.10M	714.60M	706.20M	715.00M	700.60M
Diluted Shares Outstanding	711.00M	737.20M	743.10M	737.10M	736.80M	718.70M	725.50M	710.20M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.